Peter Taylor

Aug 16, 2024 | concrete.org | Mark Snyder |Peter Taylor

DATE: August 21, 2024TIME: 1:00 pm to 2:00 pm EDTContinuing Education Credit: 0.1 CEU (1.0 PDH)Approved AIA and ICCAccess Period: 30 daysCEU (PDH) REQUIREMENTS:To earn CEU (PDH) credit, individuals must purchase the webinar and attend the live webinar for the entire duration (or pass the quiz available after the webinar).

Mar 1, 2024 | rmdopen.bmj.com | Peter Taylor |Arthur Kavanaugh |Peter Nash |Janet Pope

Impact of filgotinib on pain control in the phase 3 FINCH studies Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Nov 10, 2023 | ard.bmj.com | Peter Taylor |Michael E Weinblatt |Iain B McInnes |Tatsuya Atsumi

Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3) Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sep 11, 2023 | ard.bmj.com | Peter Taylor |Michael E Weinblatt |Iain B McInnes |Tatsuya Atsumi

Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3) Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.